Skip to main content
SpringerLink
Log in

Trials in isolated systolic hypertension: An update

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Isolated systolic hypertension (ISH) has proved to be a powerful predisposing factor for cardiovascular diseases in the elderly. Recent placebo-controlled interventional trials such as the Systolic Hypertension in the Elderly Program, the Systolic Hypertension in Europe, and the Systolic Hypertension in China showed that the lowering of systolic blood pressure using a diuretic- or a calcium antagonist-based treatment is associated with a decrease in cardiovascular events. Antihypertensive therapy was found especially effective in preventing stroke in the elderly with ISH. A slowing in the progression of dementia was observed in patients randomized to a calcium antagonistbased treatment. Patients at high cardiovascular risk such as those with diabetes benefited the most from treatment. In another trial performed in patients with left ventricular hypertrophy (Losartan Intervention For Endpoint Reduction), a subset of patients had ISH. In those patients, an angiotensin II antagonist-based treatment was superior to a β-blocker-based treatment in preventing cardiovascular complications. The experience accumulated in patients with ISH showed that combination therapy is often required to control blood pressure. Overall, the evidence available today indicates that pharmacologic treatment of ISH markedly improves the outcome of elderly patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Kannel WB: Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. Am Heart J 1999, 138:205–210.

    Article  PubMed  CAS  Google Scholar 

  2. He J, Whelton PK: Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999, 138:211–219.

    Article  PubMed  CAS  Google Scholar 

  3. Shrivastava S, Kochar MS: The need to lower systolic blood pressure. Current Hypertens Rep 2000, 2:433–440.

    CAS  Google Scholar 

  4. Staessen JA, Gasowski J, Wang JG, et al.: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000, 355:865–872. This paper reviews the outcome trials performed in elderly patients with ISH.

    Article  PubMed  CAS  Google Scholar 

  5. Franklin SS, Khan SA, Wong ND, et al.: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 1999, 100:354–360. A key observation based on the Framingham Heart Study is that pulse pressure is a powerful predicting factor for coronary heart disease.

    PubMed  CAS  Google Scholar 

  6. Benetos A, Zureik M, Morcet J, et al.: A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 2000, 35:673–680.

    Article  PubMed  CAS  Google Scholar 

  7. Joffres MR, Hamet P, MacLean DR, et al.: Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001, 14:1099–1105.

    Article  PubMed  CAS  Google Scholar 

  8. Swales JD: Current status of hypertensive disease treatment: results from the Evaluation and Interventions for Systolic Blood Pressure Elevation: Regional and Global (EISBERG) Project. J Hypertens 1999, 17:S15-S19.

    Article  CAS  Google Scholar 

  9. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255–3264.

    Article  Google Scholar 

  10. Staessen JA, Fagard R, Thijs L, et al.: Randomised doubleblind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350:757–764. Placebo-controlled trial confirming the positive effect of a calcium antagonist-based treatment in preventing stroke in patients with ISH.

    Article  PubMed  CAS  Google Scholar 

  11. Liu L, Wang JG, Gong L, et al.: Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998, 16:1823–1829.

    Article  PubMed  CAS  Google Scholar 

  12. Kjeldsen SE, Dahlof B, Devereux RB, et al.: Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002, 288:1491–1498. This trial carried out in patients with ISH shows a better protection afforded by an AT II antagonist-based treatment compared with a β-blocker-based treatment.

    Article  PubMed  CAS  Google Scholar 

  13. Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999, 17:151–183.

    Google Scholar 

  14. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997, 157:2413–2446.

  15. Waeber B: Treatment strategy to control blood pressure optimally in hypertensive patients. Blood Press 2001, 10:62–73.

    Article  PubMed  CAS  Google Scholar 

  16. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001, 358:1305–1315.

    Article  PubMed  CAS  Google Scholar 

  17. Perry HM Jr, Davis BR, Price TR, et al.: Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000, 284:465–471.

    Article  PubMed  Google Scholar 

  18. Davis BR, Vogt T, Frost PH, et al.: Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. Stroke 1998, 29:1333–1340.

    PubMed  CAS  Google Scholar 

  19. Franklin SS, Sutton-Tyrrell K, Belle SH, et al.: The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults. J Hypertens 1997, 15:1143–1150.

    Article  PubMed  CAS  Google Scholar 

  20. Sutton-Tyrrell K, Wolfson SK Jr, Kuller LH: Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic hypertension. Stroke 1994, 25:44–50.

    PubMed  CAS  Google Scholar 

  21. Pannier BM, Guerin AP, Marchais SJ, London GM: Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol 2001, 28:1074–1077.

    Article  PubMed  CAS  Google Scholar 

  22. Forette F, Boller F: Hypertension and the risk of dementia in the elderly. Am J Med 1991, 90:14–19.

    Article  Google Scholar 

  23. Forette F, Seux ML, Staessen JA, et al.: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347–1351. First trial demonstrating that antihypertensive treatment lowers the incidence of dementia in elderly patients with ISH.

    Article  PubMed  CAS  Google Scholar 

  24. Abramson J, Berger A, Krumholz HM, Vaccarino V: Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 2001, 161:1725–1730.

    Article  PubMed  CAS  Google Scholar 

  25. Applegate WB, Pressel S, Wittes J, et al.: Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 1994, 154:2154–2160.

    Article  PubMed  CAS  Google Scholar 

  26. Fletcher AE, Bulpitt CJ, Thijs L, et al.: Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial. J Hypertens 2002, 20:2069–2079.

    Article  PubMed  CAS  Google Scholar 

  27. Ofili EO, Cohen JD, St Vrain JA, et al.: Effect of treatment of isolated systolic hypertension on left ventricular mass. JAMA 1998, 279:778–780.

    Article  PubMed  CAS  Google Scholar 

  28. Dahlof B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992, 5:95–110.

    PubMed  CAS  Google Scholar 

  29. Kostis JB, Davis BR, Cutler J, et al.: Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 1997, 278:212–216.

    Article  PubMed  CAS  Google Scholar 

  30. Pahor M, Shorr RI, Somes GW, et al.: Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med 1998, 158:1340–1345.

    Article  PubMed  CAS  Google Scholar 

  31. Voyaki SM, Staessen JA, Thijs L, et al.: Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. J Hypertens 2001, 19:511–519.

    Article  PubMed  CAS  Google Scholar 

  32. Weinberger MH: Diuretics and their side effects. Dilemma in the treatment of hypertension. Hypertension 1988, 11:16–20.

    Google Scholar 

  33. Frishman WH: Beta-adrenergic receptor blockers. Adverse effects and drug interactions. Hypertension 1988, 11:21–29.

    Google Scholar 

  34. Savage PJ, Pressel SL, Curb JD, et al.: Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med 1998, 158:741–751.

    Article  PubMed  CAS  Google Scholar 

  35. Siscovick DS, Raghunathan TE, Psaty BM, et al.: Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994, 330:1852–1857.

    Article  PubMed  CAS  Google Scholar 

  36. Franse LV, Pahor M, Di Bari M, et al.: Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000, 35:1025–1030.

    PubMed  CAS  Google Scholar 

  37. Franse LV, Paor M, Di Bari M, et al.: Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000, 18:1149–1154.

    Article  PubMed  CAS  Google Scholar 

  38. Waeber B, Feihl F, Ruilope L: Diabetes and hypertension. Blood Pressure 2001, 10:311–321.

    Article  PubMed  CAS  Google Scholar 

  39. Curb JD, Pressel SL, Cutler JA, et al.: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996, 276:1886–1892.

    Article  PubMed  CAS  Google Scholar 

  40. Tuomilehto J, Rastenyte D, Birkenhager WH, et al.: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 1999, 340:677–684.

    Article  PubMed  CAS  Google Scholar 

  41. Staessen JA, Beilin L, Parati G, et al.: Task force IV: clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. Blood Press Monit 1999, 4:319–331.

    Article  PubMed  CAS  Google Scholar 

  42. Staessen JA, Thijs L, Fagard R, et al.: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999, 282:539–546.

    Article  PubMed  CAS  Google Scholar 

  43. Verdecchia P, Clement D, Fagard R, et al.: Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press Monit 1999, 4:303–317.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pathophysiology, University Hospital, BH 19, CH-1011, Lausanne, Switzerland

    Bernard Waeber MD

Authors
  1. Bernard Waeber MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waeber, B. Trials in isolated systolic hypertension: An update. Curr Cardiol Rep 5, 427–434 (2003). https://doi.org/10.1007/s11886-003-0103-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-003-0103-3

Keywords

Search

Navigation